CAMH.OB: Summary for CAMBRIDGE HEART INC - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Tuesday, November 24, 2009, 5:38am EST - Canadian Markets open in 3 hours and 52 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Cambridge Heart Inc. (CAMH.OB)

On Nov 23: 0.083 USD 0.00 (0.00%)

MORE ON CAMH.OB

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

CAMBRIDGE HEART INC (OTC BB:CAMH.OB) Delayed quote data

Last Trade:	0.083 USD
Trade Time:	Nov 23
Change:	0.00 (0.00%)
Prev Close:	0.083
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	2.30

Day's Range:	N/A - N/A
52wk Range:	0.12 - 3.90
Volume:	0
Avg Vol (3m):	132,527
Market Cap:	5.39M
P/E (ttm):	N/A
EPS (ttm):	-0.149
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add CAMH.OB to Portfolio

Download Data

HEADLINES

•	CAMBRIDGE HEART INC Financials
	EDGAR Online Financials (Sat, Nov 21)

•	Study Supports Use of MTWA Test as Predictor of Sudden Cardiac Death
	Business Wire (Wed, Nov 18)

•	Cambridge Heart Reports Results for the Third Quarter 2009
	Business Wire (Mon, Nov 16)

•	CAMBRIDGE HEART INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
	EDGAR Online (Mon, Nov 16)

•	Cardiac Science and Cambridge Heart Announce Development Partnership
	Business Wire (Thu, Nov 12)

•	Cambridge Heart to Exhibit at Sudden Cardiac Arrest Association 2009 Annual Meeting October 9th-11th
	Business Wire (Thu, Oct 8)

•	Cambridge Heart Announces New Research and Development Initiative
	Business Wire (Wed, Sep 23)

•	CAMBRIDGE HEART INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Aug 14)

•	CAMBRIDGE HEART INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
	EDGAR Online (Wed, Aug 12)

•	CAMBRIDGE HEART INC Files SEC form 8-K/A, Change in Directors or Principal Officers
	EDGAR Online (Fri, Jul 31)

More Headlines for CAMH.OB...

ANALYST

EPS Est (next year) (Dec-07) :	N/A
EPS Est (in 2 years) (Dec-08) :	N/A
Avg Rec (current)*:	2.5
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Cambridge Heart, Inc. engages in the research, development, and commercialization of products for the non-invasive diagnosis of cardiac disease in the United States and internationally.

Full Company Profile

Add to Portfolio

Email to a Friend

•